Article Information
History
- November 28, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Seth A. Wander£,1,2,3,4,
- Ofir Cohen£,1,2,4,
- Xueqian Gong£,5,
- Gabriela N. Johnson1,2,4,
- Jorge Buendia-Buendia1,2,4,
- Maxwell R. Lloyd1,2,
- Dewey Kim1,2,4,
- Flora Luo1,2,3,4,
- Pingping Mao1,2,3,4,
- Karla Helvie1,2,
- Kailey J. Kowalski1,2,4,
- Utthara Nayar1,2,3,4,
- Adrienne G. Waks1,2,3,4,
- Stephen Parsons5,
- Ricardo Martinez5,
- Lacey M. Litchfield5,
- Xiang S. Ye5,
- Chun Ping Yu5,
- Valerie M. Jansen5,
- John R. Stille5,
- Patricia S. Smith5,
- Gerard J. Oakley5,
- Quincy Chu6,
- Gerald Batist7,
- Melissa Hughes1,2,
- Jill D. Kremer5,
- Levi A. Garraway1,2,3,4,5,
- Eric P. Winer2,3,
- Sara M. Tolaney2,3,
- Nancy U. Lin2,3,
- Sean Buchanan5 and
- Nikhil Wagle1,2,3,4,*
- 1Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA
- 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
- 3Harvard Medical School, Boston, MA
- 4Broad Institute of MIT and Harvard, Cambridge, MA
- 5Eli Lilly and Co., Indianapolis, IN
- 6Cross Cancer Institute, Alberta, Canada
- 7Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Canada
- ↵*Address correspondence to: Nikhil Wagle, MD, Department of Medical Oncology Dana-Farber Cancer Institute 450 Brookline Ave, Dana 820A Boston, MA 02215, Phone: 617-632-6419, E-mail: nikhil_wagle{at}dfci.harvard.edu
↵£ These authors contributed equally